EP 4069213 A1 20221012 - CYCLOOXYGENASE-2 INHIBITION FOR THE TREATMENT OF SAA-HIGH ASTHMA
Title (en)
CYCLOOXYGENASE-2 INHIBITION FOR THE TREATMENT OF SAA-HIGH ASTHMA
Title (de)
CYCLOOXYGENASE-2 HEMMUNG ZUR BEHANDLUNG VON SAA-HIGH-ASTHMA
Title (fr)
INHIBITION DE LA CYCLOOXYGÉNASE 2 PERMETTANT LE TRAITEMENT DE L'ASTHME À SAA ÉLEVÉ
Publication
Application
Priority
- US 201962943087 P 20191203
- US 2020063090 W 20201203
Abstract (en)
[origin: WO2021113498A1] A method of treating an asthmatic subject is provided. The method includes determining serum level of serum amyloid A (SAA) in the subject; comparing the serum level with a pre-determined threshold; and administering to the subject a therapeutically effective amount of a COX-2 inhibitor if the serum level is greater than or equal to the threshold.
IPC 8 full level
A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/365 (2006.01); A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/616 (2006.01); A61K 31/635 (2006.01); A61K 45/06 (2006.01); A61P 11/06 (2006.01); G01N 33/48 (2006.01)
CPC (source: EP US)
A61K 31/167 (2013.01 - EP US); A61K 31/192 (2013.01 - EP US); A61K 31/196 (2013.01 - US); A61K 31/365 (2013.01 - EP US); A61K 31/415 (2013.01 - EP US); A61K 31/42 (2013.01 - EP US); A61K 31/616 (2013.01 - EP US); A61K 31/635 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 11/06 (2017.12 - EP US); G01N 33/6893 (2013.01 - US); G01N 2800/122 (2013.01 - EP US); G01N 2800/52 (2013.01 - EP US)
Citation (search report)
See references of WO 2021113498A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021113498 A1 20210610; EP 4069213 A1 20221012; US 2023017266 A1 20230119
DOCDB simple family (application)
US 2020063090 W 20201203; EP 20825386 A 20201203; US 202017781530 A 20201203